Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Multiplex Assays Market?

In recent times, there has been robust growth in the size of the multiplex assays market. It is projected to escalate from $3.67 billion in 2024 to $3.88 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%. The historic period’s growth is credited to factors such as heightened healthcare spending, the development of emerging markets, swift technological advancements, and a significant increase in the aging population.

The market for multiplex assays is poised for substantial expansion in the coming years, with projections estimating the market size to reach $5.33 billion by 2029, experiencing a compound annual growth rate (CAGR) of 8.2%. This anticipated growth during the forecast period is largely due to increased funding, government-led initiatives for genetic and microbiological research, a maturing populace, an escalating incidence of chronic illnesses, and the swift proliferation of different bacterial and viral outbreaks. Primary trends during this period are expected to mirror these growth drivers, namely elevated funding, governmental support for genetic and microbiological study, the growing older population, the rising frequency of chronic health conditions, and the quickened spread of various bacterial and viral epidemics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

What Drivers Are Accelerating Expansion Of The Multiplex Assays Market?

The surge in chronic diseases is propelling the expansion of the worldwide multiplex assay industry. Multiplex assays play a significant role in clinical trials for analyzing and assessing the effectiveness of disease treatments, as well as the detection of antibodies associated with the diseases. A case in point is a report from the World Health Organization, a Switzerland-based United Nations health organization, in September 2023, which stated that chronic or non-communicable diseases (NCDs) are responsible for 74% of global deaths, equivalent to 41 million fatalities. Thus, the escalating prevalence of chronic ailments is catalyzing the growth of the global multiplex assay industry.

What Are The Primary Segmentation Parameters In The Multiplex Assays Market?

The multiplex assaysmarket covered in this report is segmented –

1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types

2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies

3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies

4) By Application: Research And Development, Clinical Diagnostics

5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

Subsegments:

1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay); Luminex xMAP Technology; Western Blotting; Immunohistochemistry; Mass Spectrometry-Based Assays

2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction); qPCR (Quantitative PCR); NGS (Next-Generation Sequencing); Microarray Analysis; RT-PCR (Reverse Transcription PCR)

3) By Other Types: Cell-Based Multiplex Assays; Bioanalytical Assays; Imaging-Based Assays; Surface Plasmon Resonance (SPR) Assays

How Are Market Trends Influencing Competition In The Multiplex Assays Market?

In the market, businesses are introducing imaginative tests based on multiplex assays to solidify their market standing. For example, QuantuMDx Group Limited, a UK-based company designing revolutionary point-of-care diagnostics, unveiled its novel respiratory panel test, the Q-POC SARS-CoV-2, Flu A/B, and RSV (respiratory syncytial virus) Assay in May 2022. The Q-POCTM SARS (severe acute respiratory syndrome)-CoV-2, Flu A/B, and RSV Assay is a versatile panel capable of identifying SARS-CoV-2, Flu A, Flu B, and RSV (respiratory syncytial virus) at the point of necessity.

Which Players Are Shaping The Competitive Landscape Of The Multiplex Assays Market?

Major companies operating in the multiplex assays market include Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

What Are The Emerging Regional Trends Driving The Multiplex Assays Market?

North America was the largest region in the multiplex assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=5775&type=smp

Browse Through More Reports Similar to the Global Multiplex Assays Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model